Acrivon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ACRV Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
01 May 25	SellUS$1,017,919	Perceptive Advisors LLC	Company		736,767	US$1.41
29 Apr 25	SellUS$2,744,946	Perceptive Advisors LLC	Company		1,519,952	US$1.95

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACRV?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	2,119,646	6.76%
Individual Insiders	2,231,943	7.12%
General Public	4,390,743	14%
Institutions	9,045,400	28.8%
VC/PE Firms	13,567,252	43.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.09% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.6%	RA Capital Management, L.P.	8,340,508	US$9.2m	0%	0.14%
12.3%	Chione Ltd	3,848,632	US$4.2m	0%	43.57%
9.9%	Perceptive Advisors LLC	3,104,139	US$3.4m	-42.1%	0.12%
6.77%	Sands Capital Ventures, LLC	2,122,605	US$2.3m	0%	0.48%
6.76%	Citadel Advisors LLC	2,119,646	US$2.3m	-0.98%	no data
5.27%	Peter Blume-Jensen	1,653,851	US$1.8m	-10.7%	no data
2.99%	BlackRock, Inc.	938,707	US$1.0m	-0.72%	no data
2.83%	Wellington Management Group LLP	888,130	US$977.0k	0%	no data
2.15%	The Vanguard Group, Inc.	674,790	US$742.3k	0.47%	no data
1.91%	Marshall Wace LLP	597,794	US$657.6k	-26.2%	no data
1.29%	Acorn Bioventures	405,237	US$445.8k	0%	0.34%
0.98%	Geode Capital Management, LLC	306,111	US$336.7k	1.57%	no data
0.97%	Kristina Masson	303,578	US$333.9k	0.45%	no data
0.75%	State Street Global Advisors, Inc.	236,601	US$260.3k	4.74%	no data
0.36%	Dafna Capital Management, LLC	112,414	US$123.7k	0%	0.04%
0.36%	Charles Schwab Investment Management, Inc.	111,320	US$122.5k	-2.21%	no data
0.35%	Northern Trust Global Investments	109,025	US$119.9k	-7.07%	no data
0.33%	UBS O'Connor LLC	102,784	US$113.1k	29.7%	0.01%
0.24%	Bridgeway Capital Management, LLC	74,600	US$82.1k	-3.09%	no data
0.18%	WealthEdge Investment Advisors LLC	56,467	US$62.1k	420%	0.03%
0.17%	Baker Bros. Advisors LP	52,885	US$58.2k	0%	no data
0.17%	Eric Devroe	52,542	US$57.8k	2.66%	no data
0.16%	Sharon Shacham	51,595	US$56.8k	164%	no data
0.16%	Derek DiRocco	51,595	US$56.8k	164%	no data
0.16%	Renaissance Technologies LLC	49,400	US$54.3k	7.63%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 19:46
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Acrivon Therapeutics, Inc. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Li Wang Watsek	Cantor Fitzgerald & Co.
Silvan Tuerkcan	Citizens JMP Securities, LLC
Emily Bodnar	H.C. Wainwright & Co.